Transfection Technologies Market by Product (Kits, Equipment), Method (Physical (Electroporation, Microinjection), Biochemical (Lipofection, Calcium Phosphate), Viral), Application (Biomedical Research, Therapeutic Delivery) - Global Forecast to 2028

February 2024 | 379 pages | ID: T8EABAF175CCEN
MarketsandMarkets

Abstracts

The transfection technologies market is projected to reach USD 1.8 billion by 2028 from an estimated USD 1.2 billion in 2023, at a CAGR of 9.4% during the forecast period. The growth of this market can be attributed to the technological advancements in physical transfection methods, increasing research and development efforts in cell biology, growing focus on personalized medicines, and rising demand for advanced therapeutic products.

“The kits & reagents segment accounted for the largest share by product type in 2022.”

In 2022, the kits & reagents segment accounted for the largest share of product type in the global transfection technologies market. The factors like growing demand for high quality reagents to transfect nucleic acids into cells. The increasing focus on development of personalized medicines is also driving the growth of this market. Furthermore, the market share of the kits & reagents market is expected to grow simultaneously with the increasing need for advanced therapies.

“The North America dominated the transfection technologies market during the forecast period of 2023-2028.”

North America dominated the global transfection technologies market in 2022. This dominance is attributed to the presence of academic and research centers, often associated with drug discovery and development. Additionally, the region is experiencing increased investments in biologics and advanced dosage forms. The growing need to expedite the drug development process, which typically spans 10 to 12 years, has further fueled the demand for transfection technologies. Consequently, the North America market is witnessing growth due to the development of novel drug products and the growing research and development in cell biology efforts in the region.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 70% and Demand Side 30%
• By Designation: Managers - 45%, CXO & Directors - 30%, and Executives - 25%
• By Region: North America -35%, Europe -20%, Asia-Pacific -25%, Latin America -15% and Middle East & Africa- 5%

List of Companies Profiled in the Report:

• Thermo Fisher Scientific Inc. (US)
• Bio-Rad Laboratories, Inc. (US)
• QIAGEN (Netherlands)
• Merck KGaA (Germany)
• Sartorius AG (Polyplus) (Germany)
• Lonza (Switzerland)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Agilent Technologies, Inc. (US)
• MaxCyte (US)
• Revvity (US)
• Takara Bio Inc. (Japan)
• Promega Corporation (US)
• Danaher Corporation (US)
• BOC Sciences (US)
• RJH BIOSCIENCES (Canada)
• Synvolux (Netherlands)
• Altogen Biosciences (US)
• BioIVT (US)
• Incella GmbH (Germany)
• InvivoGen (France)
• Phoreus Biotech (US)
• STEMCELL Technologies (Canada)
• EZ Biosystems (US)
• OZ Biosciences (France)
• chemicell GmbH (Germany)

Research Coverage:

This research report categorizes the transfection technologies market by product type (kits & reagents and equipment), method (physical transfection (electroporation, bistolic technology, microinjection, and other physical transfection methods), biochemical transfection (lipofection, calcium phosphate, cationic polymer, dendrimer mediated transfection, and DEAE dextran), viral vector transfection), application (biomedical research, therapeutic delivery, protein production, and cell based microarray), end user (pharmaceutical and biotechnology companies, Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), academic and research institutes, and other end users)

The report's scope encompasses detailed information regarding major influencing factors such as drivers, trends, challenges, and opportunities shaping the growth of the transfection technologies market. A comprehensive analysis of key industry players has been conducted to offer insights into their business overview, products, key strategies, collaborations, partnerships, and agreements. The report also covers recent developments, including new product launches, mergers, and acquisitions, in the transfection technologies market.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall transfection technologies market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

• Analysis of key drivers (Increasing demand for cell and gene therapy, rising research activities and R&D funding, technological advancements), restraints (limited efficiency of transfection methods, adoption of alternative methods), opportunities (rising focus on personalized medicine, growth opportunities in emerging economies), and challenges (concerns related to cytotoxicity and transfection in hard-to-transfect cells, challenges associated with large scale transfection processes) influencing the growth of the market.
• Product Development/Innovation: Detailed insights on newly launched products of the transfection technologies market
• Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the transfection technologies market
• Competitive Assessment: Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), QIAGEN (Netherlands), Merck KGaA (Germany), Sartorius AG (Polyplus) (Germany), Lonza (Switzerland), F. Hoffmann-La Roche Ltd (Switzerland), Agilent Technologies, Inc. (US), MaxCyte (US), Revvity (US), Takara Bio Inc. (Japan), Promega Corporation (US), Danaher Corporation (US), BOC Sciences (US), RJH BIOSCIENCES (Canada), Synvolux (Netherlands), Altogen Biosciences (US), BioIVT (US), Incella GmbH (Germany), InvivoGen (France), Phoreus Biotech (US), STEMCELL Technologies (Canada), EZ Biosystems (US), OZ Biosciences (France), chemicell GmbH (Germany), and among others in the market.

Contents

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
  1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 STUDY SCOPE
  1.3.1 MARKETS COVERED
  1.3.2 YEARS CONSIDERED
  1.3.3 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
1.6 RECESSION IMPACT

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
  2.1.1 SECONDARY DATA
  2.1.2 PRIMARY DATA
FIGURE 2 TRANSFECTION TECHNOLOGIES MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET SIZE ESTIMATION
  2.2.1 BOTTOM-UP APPROACH
FIGURE 3 TRANSFECTION TECHNOLOGIES MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2022
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022
FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS, 2022
    2.2.1.1 Insights from primaries
FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS
  2.2.2 TOP-DOWN APPROACH
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
2.3 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST
FIGURE 8 TRANSFECTION TECHNOLOGIES MARKET: CAGR PROJECTIONS
FIGURE 9 TRANSFECTION TECHNOLOGIES MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.5 RESEARCH ASSUMPTIONS
2.6 LIMITATIONS
2.7 RISK ANALYSIS
2.8 RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY

FIGURE 11 TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
FIGURE 12 TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2023 VS. 2028 (USD MILLION)
FIGURE 13 TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 14 TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 15 TRANSFECTION TECHNOLOGIES MARKET: GEOGRAPHIC ANALYSIS

4 PREMIUM INSIGHTS

4.1 TRANSFECTION TECHNOLOGIES MARKET OVERVIEW
FIGURE 16 GROWING DEMAND FOR CELL AND GENE THERAPY TO DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT AND COUNTRY
FIGURE 17 KITS & REAGENTS HELD LARGEST SHARE OF ASIA PACIFIC MARKET IN 2022
4.3 TRANSFECTION TECHNOLOGIES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 18 INDIA TO REGISTER HIGHEST CAGR IN GLOBAL TRANSFECTION TECHNOLOGIES MARKET OVER FORECAST PERIOD
4.4 TRANSFECTION TECHNOLOGIES MARKET SHARE, BY PRODUCT, 2022
FIGURE 19 KITS & REAGENTS HELD LARGEST SHARE OF PRODUCTS MARKET IN 2022

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 20 TRANSFECTION TECHNOLOGIES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 1 TRANSFECTION TECHNOLOGIES MARKET: IMPACT ANALYSIS
  5.2.1 DRIVERS
    5.2.1.1 Increasing demand for cell and gene therapy
FIGURE 21 ESTIMATED CANCER CASELOAD, BY REGION
FIGURE 22 COMPARATIVE DATA FOR TOTAL NUMBER OF CLINICAL TRIALS
    5.2.1.2 Rising research activity and R&D funding
    5.2.1.3 Alliances for developing advanced therapeutic products
    5.2.1.4 Expanded applications of transfection technologies
    5.2.1.5 Technological advancements
  5.2.2 RESTRAINTS
    5.2.2.1 Limited efficiency of transfection methods
    5.2.2.2 High cost of transfection products
    5.2.2.3 Adoption of alternative methods
  5.2.3 OPPORTUNITIES
    5.2.3.1 Rising focus on personalized medicines
    5.2.3.2 Growth opportunities in emerging economies
  5.2.4 CHALLENGES
    5.2.4.1 Concern related to cytotoxicity and transfection in hard-to-transfect cells
    5.2.4.2 Challenges associated with large-scale transfection processes
5.3 PORTER’S FIVE FORCES ANALYSIS
TABLE 2 TRANSFECTION TECHNOLOGIES MARKET: PORTER’S FIVE FORCES ANALYSIS
  5.3.1 THREAT OF NEW ENTRANTS
  5.3.2 THREAT OF SUBSTITUTES
  5.3.3 BARGAINING POWER OF SUPPLIERS
  5.3.4 BARGAINING POWER OF BUYERS
  5.3.5 INTENSITY OF COMPETITIVE RIVALRY
5.4 ECOSYSTEM/MARKET MAP
FIGURE 23 TRANSFECTION TECHNOLOGIES MARKET: ECOSYSTEM
  5.4.1 PRODUCT VENDORS
TABLE 3 TRANSFECTION TECHNOLOGIES MARKET: PRODUCT VENDORS
  5.4.2 END USERS
TABLE 4 TRANSFECTION TECHNOLOGIES MARKET: END USERS
  5.4.3 REGULATORY BODIES
TABLE 5 TRANSFECTION TECHNOLOGIES MARKET: REGULATORY BODIES
5.5 SUPPLY CHAIN ANALYSIS
FIGURE 24 TRANSFECTION TECHNOLOGIES MARKET: SUPPLY CHAIN ANALYSIS
5.6 VALUE CHAIN ANALYSIS
FIGURE 25 VALUE CHAIN ANALYSIS OF TRANSFECTION TECHNOLOGIES MARKET: R&D AND MANUFACTURING PHASES ADD MAXIMUM VALUE
5.7 REGULATORY LANDSCAPE
  5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 6 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.8 PRICING ANALYSIS
TABLE 10 AVERAGE SELLING PRICE, BY COMPANY, 2022
TABLE 11 AVERAGE SELLING PRICE, BY REGION
5.9 TECHNOLOGY ANALYSIS
TABLE 12 TRANSFECTION TECHNOLOGIES MARKET: PROMINENT TECHNOLOGIES AND THEIR IMPACTS
5.10 PATENT ANALYSIS
FIGURE 26 PATENT APPLICATIONS FOR TRANSFECTION TECHNOLOGIES MARKET, JANUARY 2013–OCTOBER 2023
TABLE 13 TRANSFECTION TECHNOLOGIES MARKET: INDICATIVE LIST OF PATENTS
5.11 KEY CONFERENCES AND EVENTS, 2024–2025
TABLE 14 TRANSFECTION TECHNOLOGIES MARKET: DETAILED LIST OF CONFERENCES AND EVENTS, 2024–2025
5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 27 REVENUE SHIFT AND NEW POCKETS FOR TRANSFECTION PRODUCT PROVIDERS
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
  5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TRANSFECTION PRODUCTS
  5.13.2 BUYING CRITERIA FOR TRANSFECTION PRODUCTS
FIGURE 29 KEY BUYING CRITERIA FOR END USERS
TABLE 15 KEY BUYING CRITERIA FOR END USERS

6 TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT

6.1 INTRODUCTION
TABLE 16 TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
6.2 KITS & REAGENTS
  6.2.1 KITS & REAGENTS SEGMENT TO HOLD LARGEST SHARE OF PRODUCTS MARKET
TABLE 17 TRANSFECTION KITS & REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 18 NORTH AMERICA: TRANSFECTION KITS & REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 19 EUROPE: TRANSFECTION KITS & REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 20 ASIA PACIFIC: TRANSFECTION KITS & REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 21 LATIN AMERICA: TRANSFECTION KITS & REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 22 MIDDLE EAST & AFRICA: TRANSFECTION KITS & REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 23 MIDDLE EAST: TRANSFECTION KITS & REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3 EQUIPMENT
  6.3.1 TECHNOLOGICAL DEVELOPMENTS AND RISING ADOPTION OF INNOVATIVE PRODUCTS TO BOOST MARKET GROWTH
TABLE 24 TRANSFECTION EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 25 NORTH AMERICA: TRANSFECTION EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 26 EUROPE: TRANSFECTION EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 27 ASIA PACIFIC: TRANSFECTION EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 28 LATIN AMERICA: TRANSFECTION EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 29 MIDDLE EAST & AFRICA: TRANSFECTION EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 30 MIDDLE EAST: TRANSFECTION EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION)

7 TRANSFECTION TECHNOLOGIES MARKET, BY METHOD

7.1 INTRODUCTION
TABLE 31 TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)
7.2 PHYSICAL TRANSFECTION
TABLE 32 PHYSICAL TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 33 NORTH AMERICA: PHYSICAL TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 34 EUROPE: PHYSICAL TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 35 ASIA PACIFIC: PHYSICAL TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 36 LATIN AMERICA: PHYSICAL TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 37 MIDDLE EAST & AFRICA: PHYSICAL TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 38 MIDDLE EAST: PHYSICAL TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 39 PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  7.2.1 ELECTROPORATION
    7.2.1.1 Growing demand for efficient cell transfection technologies to drive growth
TABLE 40 ELECTROPORATION MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 41 NORTH AMERICA: ELECTROPORATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 42 EUROPE: ELECTROPORATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 43 ASIA PACIFIC: ELECTROPORATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 44 LATIN AMERICA: ELECTROPORATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 45 MIDDLE EAST & AFRICA: ELECTROPORATION MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 46 MIDDLE EAST: ELECTROPORATION MARKET, BY REGION, 2021–2028 (USD MILLION)
  7.2.2 BIOLISTIC TRANSFECTION/GENE GUNS
    7.2.2.1 Increasing focus on rapid and simple techniques to support market growth
TABLE 47 BIOLISTIC TRANSFECTION/GENE GUNS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 48 NORTH AMERICA: BIOLISTIC TRANSFECTION/GENE GUNS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 49 EUROPE: BIOLISTIC TRANSFECTION/GENE GUNS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 50 ASIA PACIFIC: BIOLISTIC TRANSFECTION/GENE GUNS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 51 LATIN AMERICA: BIOLISTIC TRANSFECTION/GENE GUNS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 52 MIDDLE EAST & AFRICA: BIOLISTIC TRANSFECTION/GENE GUNS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 53 MIDDLE EAST: BIOLISTIC TRANSFECTION/GENE GUNS MARKET, BY REGION, 2021–2028 (USD MILLION)
  7.2.3 MICROINJECTION
    7.2.3.1 Rising need for advanced cell transfection techniques to drive adoption
TABLE 54 MICROINJECTION MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 55 NORTH AMERICA: MICROINJECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 56 EUROPE: MICROINJECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 57 ASIA PACIFIC: MICROINJECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 58 LATIN AMERICA: MICROINJECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 59 MIDDLE EAST & AFRICA: MICROINJECTION MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 60 MIDDLE EAST: MICROINJECTION MARKET, BY REGION, 2021–2028 (USD MILLION)
  7.2.4 OTHER PHYSICAL TRANSFECTION METHODS
TABLE 61 OTHER PHYSICAL TRANSFECTION METHODS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 62 NORTH AMERICA: OTHER PHYSICAL TRANSFECTION METHODS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 63 EUROPE: OTHER PHYSICAL TRANSFECTION METHODS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 64 ASIA PACIFIC: OTHER PHYSICAL TRANSFECTION METHODS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 65 LATIN AMERICA: OTHER PHYSICAL TRANSFECTION METHODS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 66 MIDDLE EAST & AFRICA: OTHER PHYSICAL TRANSFECTION METHODS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 67 MIDDLE EAST: OTHER PHYSICAL TRANSFECTION METHODS MARKET, BY REGION, 2021–2028 (USD MILLION)
7.3 BIOCHEMICAL-BASED TRANSFECTION
TABLE 68 BIOCHEMICAL-BASED TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 69 NORTH AMERICA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 70 EUROPE: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 71 ASIA PACIFIC: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 72 LATIN AMERICA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 73 MIDDLE EAST & AFRICA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 74 MIDDLE EAST: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 75 BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  7.3.1 LIPOFECTION
    7.3.1.1 High efficiency and compatibility to drive adoption
TABLE 76 LIPOFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 77 NORTH AMERICA: LIPOFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 78 EUROPE: LIPOFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 79 ASIA PACIFIC: LIPOFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 80 LATIN AMERICA: LIPOFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 81 MIDDLE EAST & AFRICA: LIPOFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 82 MIDDLE EAST: LIPOFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)
  7.3.2 CALCIUM PHOSPHATE TRANSFECTION
    7.3.2.1 Increasing R&D in cell-based therapies to drive market
TABLE 83 CALCIUM PHOSPHATE TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 84 NORTH AMERICA: CALCIUM PHOSPHATE TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 85 EUROPE: CALCIUM PHOSPHATE TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 86 ASIA PACIFIC: CALCIUM PHOSPHATE TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 87 LATIN AMERICA: CALCIUM PHOSPHATE TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 88 MIDDLE EAST & AFRICA: CALCIUM PHOSPHATE TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 89 MIDDLE EAST: CALCIUM PHOSPHATE TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)
  7.3.3 CATIONIC POLYMER TRANSFECTION
    7.3.3.1 Adoption of innovative biochemical materials for transfection to accelerate growth
TABLE 90 CATIONIC POLYMER TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 91 NORTH AMERICA: CATIONIC POLYMER TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 92 EUROPE: CATIONIC POLYMER TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 93 ASIA PACIFIC: CATIONIC POLYMER TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 94 LATIN AMERICA: CATIONIC POLYMER TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 95 MIDDLE EAST & AFRICA: CATIONIC POLYMER TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 96 MIDDLE EAST: CATIONIC POLYMER TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)
  7.3.4 DEAE-DEXTRAN TRANSFECTION
    7.3.4.1 Simplicity, rapidity, and cost-effectiveness to support adoption
TABLE 97 DEAE-DEXTRAN TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 98 NORTH AMERICA: DEAE-DEXTRAN TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 99 EUROPE: DEAE-DEXTRAN TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 100 ASIA PACIFIC: DEAE-DEXTRAN TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 101 LATIN AMERICA: DEAE-DEXTRAN TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 102 MIDDLE EAST & AFRICA: DEAE-DEXTRAN TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 103 MIDDLE EAST: DEAE-DEXTRAN TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)
  7.3.5 MAGNET-ASSISTED TRANSFECTION
    7.3.5.1 Rising emphasis on innovative therapies for genetic disorders to drive adoption
TABLE 104 MAGNET-ASSISTED TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 105 NORTH AMERICA: MAGNET-ASSISTED TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 106 EUROPE: MAGNET-ASSISTED TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 107 ASIA PACIFIC: MAGNET-ASSISTED TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 108 LATIN AMERICA: MAGNET-ASSISTED TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 109 MIDDLE EAST & AFRICA: MAGNET-ASSISTED TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 110 MIDDLE EAST: MAGNET-ASSISTED TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)
  7.3.6 DENDRIMER-MEDIATED TRANSFECTION
    7.3.6.1 Non-biodegradable properties to restrain market growth
TABLE 111 DENDRIMER-MEDIATED TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 112 NORTH AMERICA: DENDRIMER-MEDIATED TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 113 EUROPE: DENDRIMER-MEDIATED TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 114 ASIA PACIFIC: DENDRIMER-MEDIATED TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 115 LATIN AMERICA: DENDRIMER-MEDIATED TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 116 MIDDLE EAST & AFRICA: DENDRIMER-MEDIATED TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 117 MIDDLE EAST: DENDRIMER-MEDIATED TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)
7.4 VIRAL-VECTOR BASED TRANSFECTION
  7.4.1 TECHNOLOGICAL DEVELOPMENTS AND GROWING NEED FOR CELL & GENE THERAPY TO DRIVE MARKET
TABLE 118 VIRAL VECTOR-BASED TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 119 NORTH AMERICA: VIRAL VECTOR-BASED TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 120 EUROPE: VIRAL VECTOR-BASED TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 121 ASIA PACIFIC: VIRAL VECTOR-BASED TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 122 LATIN AMERICA: VIRAL VECTOR-BASED TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 123 MIDDLE EAST & AFRICA: VIRAL VECTOR-BASED TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 124 MIDDLE EAST: VIRAL VECTOR-BASED TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)

8 TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION

8.1 INTRODUCTION
TABLE 125 TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.2 THERAPEUTIC DELIVERY
TABLE 126 TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY REGION, 2021–2028 (USD MILLION)
TABLE 127 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 128 EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 129 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 130 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 131 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY REGION, 2021–2028 (USD MILLION)
TABLE 132 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY REGION, 2021–2028 (USD MILLION)
TABLE 133 TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)
  8.2.1 BIOTHERAPEUTICS
    8.2.1.1 Rising need for cell and gene therapy to promote growth
TABLE 134 TRANSFECTION TECHNOLOGIES MARKET FOR BIOTHERAPEUTICS, BY REGION, 2021–2028 (USD MILLION)
TABLE 135 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOTHERAPEUTICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 136 EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR BIOTHERAPEUTICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 137 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR BIOTHERAPEUTICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 138 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOTHERAPEUTICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 139 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOTHERAPEUTICS, BY REGION, 2021–2028 (USD MILLION)
TABLE 140 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR BIOTHERAPEUTICS, BY REGION, 2021–2028 (USD MILLION)
  8.2.2 ELECTROIMMUNOTHERAPY
    8.2.2.1 Increasing rate of chronic and immunological diseases to accelerate market growth
TABLE 141 TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROIMMUNOTHERAPY, BY REGION, 2021–2028 (USD MILLION)
TABLE 142 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROIMMUNOTHERAPY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 143 EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROIMMUNOTHERAPY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 144 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROIMMUNOTHERAPY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 145 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROIMMUNOTHERAPY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 146 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROIMMUNOTHERAPY, BY REGION, 2021–2028 (USD MILLION)
TABLE 147 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROIMMUNOTHERAPY, BY REGION, 2021–2028 (USD MILLION)
  8.2.3 ELECTROCHEMOTHERAPY
    8.2.3.1 Need for advanced chemotherapy due to rising cancer incidence to drive market
TABLE 148 TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROCHEMOTHERAPY, BY REGION, 2021–2028 (USD MILLION)
TABLE 149 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROCHEMOTHERAPY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 150 EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROCHEMOTHERAPY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 151 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROCHEMOTHERAPY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 152 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROCHEMOTHERAPY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 153 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROCHEMOTHERAPY, BY REGION, 2021–2028 (USD MILLION)
TABLE 154 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROCHEMOTHERAPY, BY REGION, 2021–2028 (USD MILLION)
8.3 BIOMEDICAL RESEARCH
TABLE 155 TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY REGION, 2021–2028 (USD MILLION)
TABLE 156 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 157 EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 158 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 159 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 160 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY REGION, 2021–2028 (USD MILLION)
TABLE 161 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY REGION, 2021–2028 (USD MILLION)
TABLE 162 TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)
  8.3.1 GENE & PROTEIN EXPRESSION STUDIES
    8.3.1.1 Efforts to develop advanced gene therapy and genomic medicine promote growth
TABLE 163 TRANSFECTION TECHNOLOGIES MARKET FOR GENE & PROTEIN EXPRESSION STUDIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 164 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR GENE & PROTEIN EXPRESSION STUDIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 165 EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR GENE & PROTEIN EXPRESSION STUDIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 166 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR GENE & PROTEIN EXPRESSION STUDIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 167 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR GENE & PROTEIN EXPRESSION STUDIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 168 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR GENE & PROTEIN EXPRESSION STUDIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 169 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR GENE & PROTEIN EXPRESSION STUDIES, BY REGION, 2021–2028 (USD MILLION)
  8.3.2 CANCER RESEARCH
    8.3.2.1 Increasing prevalence of cancer to propel market growth
TABLE 170 TRANSFECTION TECHNOLOGIES MARKET FOR CANCER RESEARCH, BY REGION, 2021–2028 (USD MILLION)
TABLE 171 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR CANCER RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 172 EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR CANCER RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 173 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR CANCER RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 174 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR CANCER RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 175 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR CANCER RESEARCH, BY REGION, 2021–2028 (USD MILLION)
TABLE 176 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR CANCER RESEARCH, BY REGION, 2021–2028 (USD MILLION)
  8.3.3 TRANSGENIC MODELS
    8.3.3.1 Growing R&D activities and clinical studies to drive market
TABLE 177 TRANSFECTION TECHNOLOGIES MARKET FOR TRANSGENIC MODELS, BY REGION, 2021–2028 (USD MILLION)
TABLE 178 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR TRANSGENIC MODELS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 179 EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR TRANSGENIC MODELS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 180 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR TRANSGENIC MODELS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 181 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR TRANSGENIC MODELS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 182 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR TRANSGENIC MODELS, BY REGION, 2021–2028 (USD MILLION)
TABLE 183 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR TRANSGENIC MODELS, BY REGION, 2021–2028 (USD MILLION)
8.4 PROTEIN PRODUCTION
  8.4.1 INCREASING INCIDENCE OF CHRONIC DISEASES AND DEMAND FOR PROTEIN THERAPEUTICS TO PROMOTE GROWTH
TABLE 184 TRANSFECTION TECHNOLOGIES MARKET FOR PROTEIN PRODUCTION, BY REGION, 2021–2028 (USD MILLION)
TABLE 185 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR PROTEIN PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 186 EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR PROTEIN PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 187 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR PROTEIN PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 188 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR PROTEIN PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 189 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR PROTEIN PRODUCTION, BY REGION, 2021–2028 (USD MILLION)
TABLE 190 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR PROTEIN PRODUCTION, BY REGION, 2021–2028 (USD MILLION)
8.5 CELL-BASED MICROARRAYS
  8.5.1 INCREASING NEED FOR CELL-BASED THERAPIES TO DRIVE MARKET
TABLE 191 TRANSFECTION TECHNOLOGIES MARKET FOR CELL-BASED MICROARRAYS, BY REGION, 2021–2028 (USD MILLION)
TABLE 192 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR CELL-BASED MICROARRAYS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 193 EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR CELL-BASED MICROARRAYS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 194 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR CELL-BASED MICROARRAYS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 195 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR CELL-BASED MICROARRAYS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 196 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR CELL-BASED MICROARRAYS, BY REGION, 2021–2028 (USD MILLION)
TABLE 197 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR CELL-BASED MICROARRAYS, BY REGION, 2021–2028 (USD MILLION)

9 TRANSFECTION TECHNOLOGIES MARKET, BY END USER

9.1 INTRODUCTION
TABLE 198 TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  9.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE END-USER MARKET
TABLE 199 TRANSFECTION TECHNOLOGIES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 200 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 201 EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 202 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 203 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 204 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 205 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)
9.3 CROS & CDMOS
  9.3.1 CONTRACT RESEARCH AND MANUFACTURING SECTOR TO SEE STRONG GROWTH
TABLE 206 TRANSFECTION TECHNOLOGIES MARKET FOR CROS & CDMOS, BY REGION, 2021–2028 (USD MILLION)
TABLE 207 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR CROS & CDMOS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 208 EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR CROS & CDMOS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 209 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR CROS & CDMOS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 210 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR CROS & CDMOS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 211 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR CROS & CDMOS, BY REGION, 2021–2028 (USD MILLION)
TABLE 212 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR CROS & CDMOS, BY REGION, 2021–2028 (USD MILLION)
9.4 ACADEMIC & RESEARCH INSTITUTES
  9.4.1 INCREASING R&D AND GROWING TREND OF COLLABORATIVE RESEARCH TO PROMOTE MARKET GROWTH
TABLE 213 TRANSFECTION TECHNOLOGIES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
TABLE 214 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 215 EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 216 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 217 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 218 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
TABLE 219 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
9.5 OTHER END USERS
TABLE 220 TRANSFECTION TECHNOLOGIES MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)
TABLE 221 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 222 EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 223 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 224 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 225 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)
TABLE 226 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)

10 TRANSFECTION TECHNOLOGIES MARKET, BY REGION

10.1 INTRODUCTION
TABLE 227 TRANSFECTION TECHNOLOGIES MARKET, BY REGION, 2021–2028 (USD MILLION)
10.2 NORTH AMERICA
  10.2.1 NORTH AMERICA: RECESSION IMPACT
FIGURE 30 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SNAPSHOT
TABLE 228 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 229 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 230 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 231 NORTH AMERICA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 232 NORTH AMERICA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 233 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 234 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 235 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)
TABLE 236 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)
  10.2.2 US
    10.2.2.1 US to dominate North American market
TABLE 237 US: INDICATIVE LIST OF THERAPIES APPROVED IN 2022
TABLE 238 US: INDICATIVE LIST OF PRODUCTS ANTICIPATED TO BE APPROVED IN 2023
TABLE 239 US: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 240 US: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 241 US: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 242 US: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 243 US: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 244 US: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 245 US: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)
TABLE 246 US: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)
  10.2.3 CANADA
    10.2.3.1 Rising investments in R&D to drive market
TABLE 247 CANADA: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 248 CANADA: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 249 CANADA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 250 CANADA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 251 CANADA: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 252 CANADA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 253 CANADA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)
TABLE 254 CANADA: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3 EUROPE
TABLE 255 EUROPE: INDICATIVE LIST OF THERAPIES APPROVED IN 2022
TABLE 256 EUROPE: INDICATIVE LIST OF PRODUCTS ANTICIPATED TO BE APPROVED IN 2023
  10.3.1 EUROPE: RECESSION IMPACT
TABLE 257 EUROPE: TRANSFECTION TECHNOLOGIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 258 EUROPE: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 259 EUROPE: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 260 EUROPE: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 261 EUROPE: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 262 EUROPE: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 263 EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 264 EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)
TABLE 265 EUROPE: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)
  10.3.2 GERMANY
    10.3.2.1 Germany to hold largest share of European market till 2028
TABLE 266 GERMANY: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 267 GERMANY: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 268 GERMANY: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 269 GERMANY: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 270 GERMANY: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 271 GERMANY: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 272 GERMANY: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)
TABLE 273 GERMANY: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)
  10.3.3 UK
    10.3.3.1 Increasing government funding for genomic projects to drive market
TABLE 274 UK: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 275 UK: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 276 UK: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 277 UK: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 278 UK: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 279 UK: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 280 UK: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)
TABLE 281 UK: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)
  10.3.4 FRANCE
    10.3.4.1 Focus on collaborative development of advanced cell and gene therapies to promote market growth
TABLE 282 FRANCE: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 283 FRANCE: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 284 FRANCE: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 285 FRANCE: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 286 FRANCE: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 287 FRANCE: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 288 FRANCE: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)
TABLE 289 FRANCE: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)
  10.3.5 ITALY
    10.3.5.1 Rising R&D investments and growing biotech industry to drive market
TABLE 290 ITALY: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 291 ITALY: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 292 ITALY: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 293 ITALY: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 294 ITALY: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 295 ITALY: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 296 ITALY: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)
TABLE 297 ITALY: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)
  10.3.6 SPAIN
    10.3.6.1 Growing expansion of research centers to stimulate market growth
TABLE 298 SPAIN: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 299 SPAIN: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 300 SPAIN: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 301 SPAIN: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 302 SPAIN: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 303 SPAIN: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 304 SPAIN: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)
TABLE 305 SPAIN: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)
  10.3.7 REST OF EUROPE
TABLE 306 REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 307 REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 308 REST OF EUROPE: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 309 REST OF EUROPE: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 310 REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 311 REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 312 REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)
TABLE 313 REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4 ASIA PACIFIC
  10.4.1 ASIA PACIFIC: RECESSION IMPACT
FIGURE 31 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SNAPSHOT
TABLE 314 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 315 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 316 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 317 ASIA PACIFIC: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 318 ASIA PACIFIC: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 319 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 320 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 321 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)
TABLE 322 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)
  10.4.2 CHINA
    10.4.2.1 Increasing R&D expenditure to propel market growth
TABLE 323 CHINA: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 324 CHINA: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 325 CHINA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 326 CHINA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 327 CHINA: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 328 CHINA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 329 CHINA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)
TABLE 330 CHINA: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)
  10.4.3 JAPAN
    10.4.3.1 Booming CGT & RM sector to drive market
TABLE 331 JAPAN: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 332 JAPAN: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 333 JAPAN: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 334 JAPAN: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 335 JAPAN: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 336 JAPAN: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 337 JAPAN: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)
TABLE 338 JAPAN: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)
  10.4.4 SOUTH KOREA
    10.4.4.1 Alliances and investments in research to drive market
TABLE 339 SOUTH KOREA: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 340 SOUTH KOREA: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 341 SOUTH KOREA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 342 SOUTH KOREA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 343 SOUTH KOREA: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 344 SOUTH KOREA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 345 SOUTH KOREA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)
TABLE 346 SOUTH KOREA: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)
  10.4.5 INDIA
    10.4.5.1 Growing demand for advanced treatment solutions to propel market growth
TABLE 347 INDIA: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 348 INDIA: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 349 INDIA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 350 INDIA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 351 INDIA: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 352 INDIA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 353 INDIA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)
TABLE 354 INDIA: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)
  10.4.6 AUSTRALIA
    10.4.6.1 Rising prevalence of chronic diseases and growing life science sector to drive market
TABLE 355 AUSTRALIA: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 356 AUSTRALIA: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 357 AUSTRALIA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 358 AUSTRALIA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 359 AUSTRALIA: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 360 AUSTRALIA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 361 AUSTRALIA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)
TABLE 362 AUSTRALIA: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)
  10.4.7 REST OF ASIA PACIFIC
TABLE 363 REST OF ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 364 REST OF ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 365 REST OF ASIA PACIFIC: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 366 REST OF ASIA PACIFIC: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 367 REST OF ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 368 REST OF ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 369 REST OF ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)
TABLE 370 REST OF ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5 LATIN AMERICA
  10.5.1 LATIN AMERICA: RECESSION IMPACT
TABLE 371 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 372 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 373 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 374 LATIN AMERICA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 375 LATIN AMERICA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 376 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 377 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 378 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)
TABLE 379 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)
  10.5.2 BRAZIL
    10.5.2.1 Brazil to hold largest share of LATAM market
TABLE 380 BRAZIL: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 381 BRAZIL: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 382 BRAZIL: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 383 BRAZIL: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 384 BRAZIL: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 385 BRAZIL: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 386 BRAZIL: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)
TABLE 387 BRAZIL: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)
  10.5.3 MEXICO
    10.5.3.1 Rising research activity to support market growth
TABLE 388 MEXICO: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 389 MEXICO: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 390 MEXICO: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 391 MEXICO: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 392 MEXICO: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 393 MEXICO: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 394 MEXICO: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)
TABLE 395 MEXICO: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)
  10.5.4 ARGENTINA
    10.5.4.1 Increasing government initiatives to drive market
TABLE 396 ARGENTINA: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 397 ARGENTINA: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 398 ARGENTINA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 399 ARGENTINA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 400 ARGENTINA: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 401 ARGENTINA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 402 ARGENTINA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)
TABLE 403 ARGENTINA: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)
  10.5.5 REST OF LATIN AMERICA
TABLE 404 REST OF LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 405 REST OF LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 406 REST OF LATIN AMERICA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 407 REST OF LATIN AMERICA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 408 REST OF LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 409 REST OF LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 410 REST OF LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)
TABLE 411 REST OF LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
  10.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT
TABLE 412 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 413 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 414 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 415 MIDDLE EAST & AFRICA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 416 MIDDLE EAST & AFRICA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 417 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 418 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 419 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)
TABLE 420 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)
  10.6.2 MIDDLE EAST
TABLE 421 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 422 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 423 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 424 MIDDLE EAST: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 425 MIDDLE EAST: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 426 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 427 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 428 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)
TABLE 429 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)
    10.6.2.1 GCC Countries
      10.6.2.1.1 Increasing collaborations and partnerships to advance cell therapy to drive market
TABLE 430 GCC COUNTRIES: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 431 GCC COUNTRIES: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 432 GCC COUNTRIES: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 433 GCC COUNTRIES: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 434 GCC COUNTRIES: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 435 GCC COUNTRIES: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 436 GCC COUNTRIES: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)
TABLE 437 GCC COUNTRIES: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)
    10.6.2.2 Rest of the Middle East
TABLE 438 REST OF MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 439 REST OF MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 440 REST OF MIDDLE EAST: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 441 REST OF MIDDLE EAST: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 442 REST OF MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 443 REST OF MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 444 REST OF MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)
TABLE 445 REST OF MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)
  10.6.3 AFRICA
    10.6.3.1 Rising prevalence of HIV and cancer and growing precision medicine initiatives to fuel market growth
TABLE 446 AFRICA: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 447 AFRICA: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 448 AFRICA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 449 AFRICA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 450 AFRICA: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 451 AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 452 AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)
TABLE 453 AFRICA: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)

11 COMPETITIVE LANDSCAPE

11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
11.3 REVENUE SHARE ANALYSIS
11.4 MARKET SHARE ANALYSIS
FIGURE 34 TRANSFECTION TECHNOLOGIES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022
TABLE 454 TRANSFECTION TECHNOLOGIES MARKET: DEGREE OF COMPETITION
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS
  11.5.1 STARS
  11.5.2 EMERGING LEADERS
  11.5.3 PERVASIVE PLAYERS
  11.5.4 PARTICIPANTS
  11.5.5 COMPANY FOOTPRINT
TABLE 455 COMPANY FOOTPRINT
TABLE 456 COMPANY PRODUCT FOOTPRINT
TABLE 457 COMPANY REGION FOOTPRINT
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES
  11.6.1 PROGRESSIVE COMPANIES
  11.6.2 RESPONSIVE COMPANIES
  11.6.3 DYNAMIC COMPANIES
  11.6.4 STARTING BLOCKS
FIGURE 36 TRANSFECTION TECHNOLOGIES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES) (2022)
  11.6.5 COMPETITIVE BENCHMARKING
TABLE 458 TRANSFECTION TECHNOLOGIES MARKET: KEY STARTUPS/SMES
TABLE 459 TRANSFECTION TECHNOLOGIES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
11.7 COMPETITIVE SCENARIO
  11.7.1 PRODUCT LAUNCHES
TABLE 460 TRANSFECTION TECHNOLOGIES MARKET: KEY PRODUCT LAUNCHES, JANUARY 2020?DECEMBER 2023
  11.7.2 DEALS
TABLE 461 TRANSFECTION TECHNOLOGIES MARKET: KEY DEALS, JANUARY 2020? DECEMBER 2023
  11.7.3 OTHER DEVELOPMENTS
TABLE 462 TRANSFECTION TECHNOLOGIES MARKET: OTHER DEVELOPMENTS, JANUARY 2020?NOVEMBER 2023

12 COMPANY PROFILES

12.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
  12.1.1 THERMO FISHER SCIENTIFIC INC.
TABLE 463 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
FIGURE 37 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
TABLE 464 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
TABLE 465 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES
TABLE 466 THERMO FISHER SCIENTIFIC INC.: DEALS
TABLE 467 THERMO FISHER SCIENTIFIC INC.: OTHER DEVELOPMENTS
  12.1.2 BIO-RAD LABORATORIES, INC.
TABLE 468 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 38 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
TABLE 469 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED
  12.1.3 QIAGEN
TABLE 470 QIAGEN: BUSINESS OVERVIEW
FIGURE 39 QIAGEN: COMPANY SNAPSHOT (2022)
TABLE 471 QIAGEN: PRODUCTS OFFERED
  12.1.4 MERCK KGAA
TABLE 472 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 40 MERCK KGAA: COMPANY SNAPSHOT (2022)
TABLE 473 MERCK KGAA: PRODUCTS OFFERED
TABLE 474 MERCK KGAA: DEALS
TABLE 475 MERCK KGAA: OTHER DEVELOPMENTS
  12.1.5 SARTORIUS AG (POLYPLUS)
TABLE 476 SARTORIUS AG (POLYPLUS): BUSINESS OVERVIEW
FIGURE 41 SARTORIUS AG (POLYPLUS): COMPANY SNAPSHOT (2022)
TABLE 477 SARTORIUS AG (POLYPLUS): PRODUCTS OFFERED
TABLE 478 SARTORIUS AG (POLYPLUS): PRODUCT LAUNCHES
TABLE 479 SARTORIUS AG (POLYPLUS): DEALS
  12.1.6 LONZA
TABLE 480 LONZA: BUSINESS OVERVIEW
FIGURE 42 LONZA: COMPANY SNAPSHOT (2022)
TABLE 481 LONZA: PRODUCTS OFFERED
TABLE 482 LONZA: PRODUCT LAUNCHES
TABLE 483 LONZA: DEALS
  12.1.7 F. HOFFMANN-LA ROCHE LTD.
TABLE 484 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
FIGURE 43 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022)
TABLE 485 F. HOFFMAN-LA ROCHE LTD.: PRODUCTS OFFERED
  12.1.8 AGILENT TECHNOLOGIES, INC.
TABLE 486 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
FIGURE 44 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022)
TABLE 487 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED
TABLE 488 AGILENT TECHNOLOGIES, INC.: DEALS
  12.1.9 MAXCYTE
TABLE 489 MAXCYTE: BUSINESS OVERVIEW
FIGURE 45 MAXCYTE: COMPANY SNAPSHOT (2022)
TABLE 490 MAXCYTE: PRODUCTS OFFERED
TABLE 491 MAXCYTE: PRODUCT LAUNCHES
TABLE 492 MAXCYTE: DEALS
  12.1.10 REVVITY
TABLE 493 REVVITY: BUSINESS OVERVIEW
FIGURE 46 REVVITY: COMPANY SNAPSHOT (2022)
TABLE 494 REVVITY: PRODUCTS OFFERED
TABLE 495 REVVITY: DEALS
TABLE 496 REVVITY: OTHER DEVELOPMENTS
  12.1.11 TAKARA BIO INC.
TABLE 497 TAKARA BIO INC.: BUSINESS OVERVIEW
FIGURE 47 TAKARA BIO INC.: COMPANY SNAPSHOT (2022)
TABLE 498 TAKARA BIO INC.: COMPANY OVERVIEW
  12.1.12 PROMEGA CORPORATION
TABLE 499 PROMEGA CORPORATION: BUSINESS OVERVIEW
TABLE 500 PROMEGA CORPORATION: PRODUCTS OFFERED
  12.1.13 DANAHER CORPORATION
TABLE 501 DANAHER CORPORATION: BUSINESS OVERVIEW
FIGURE 48 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
TABLE 502 DANAHER CORPORATION: PRODUCTS OFFERED
TABLE 503 DANAHER CORPORATION: PRODUCT LAUNCHES
TABLE 504 DANAHER CORPORATION: DEALS
TABLE 505 DANAHER CORPORATION: OTHER DEVELOPMENTS
12.2 OTHER PLAYERS
  12.2.1 BOC SCIENCES
TABLE 506 BOC SCIENCES: COMPANY OVERVIEW
  12.2.2 RJH BIOSCIENCES
TABLE 507 RJH BIOSCIENCES: COMPANY OVERVIEW
  12.2.3 SYNVOLUX
TABLE 508 SYNVOLUX: COMPANY OVERVIEW
  12.2.4 ALTOGEN BIOSYSTEMS
TABLE 509 ALTOGEN BIOSYSTEMS: COMPANY OVERVIEW
  12.2.5 BIOIVT
TABLE 510 BIOIVT: COMPANY OVERVIEW
  12.2.6 INCELLA GMBH
TABLE 511 INCELLA GMBH (SCREENFECT): COMPANY OVERVIEW
  12.2.7 INVIVOGEN
TABLE 512 INVIVOGEN: COMPANY OVERVIEW
  12.2.8 PHOREUS BIOTECH
TABLE 513 PHOREUS BIOTECH: COMPANY OVERVIEW
  12.2.9 STEMCELL TECHNOLOGIES
TABLE 514 STEMCELL TECHNOLOGIES: COMPANY OVERVIEW
  12.2.10 EZ BIOSYSTEMS
TABLE 515 EZ BIOSYSTEMS: COMPANY OVERVIEW
  12.2.11 OZ BIOSCIENCES
TABLE 516 OZ BIOSCIENCES: COMPANY OVERVIEW
  12.2.12 CHEMICELL GMBH
TABLE 517 CHEMICELL GMBH: COMPANY OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 APPENDIX

13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS